Cleared Traditional

K190875 - EVA

K190875 is an FDA 510(k) clearance for EVA, manufactured by D.O.R.C. Dutch Ophthalmic Research Center (International). The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 174-day FDA review.

K190875 · D.O.R.C. Dutch Ophthalmic Research Center (International) · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
174d
Days
Class 2
Risk

K190875 is an FDA 510(k) clearance for the EVA, anterior machine, EVA, combined machine, EVA combined machine with laser.... Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by D.O.R.C. Dutch Ophthalmic Research Center (International) (Zuidland, NL). The FDA issued a Cleared decision on September 25, 2019 after a review of 174 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all D.O.R.C. Dutch Ophthalmic Research Center (International) devices

FDA 510(k) Submission Details - K190875

510(k) Number K190875 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 2019
Decision Date September 25, 2019
Days to Decision 174 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 110d · This submission: 174d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 121
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K190875.
Visalis V500, Visalis S500
K193376 · Carl Zeiss Meditec, AG · Jun 2020
Phacoemulsification Needle (Tip) and Irrigation Sleeve
K192418 · Raico, LLC · May 2020
LEGION System
K191650 · Alcon Research, LLC · Nov 2019
COMPACT INTUITIV System, COMPACT INTUITIV Wireless Remote Control, COMPACT INTUITIV Four-Button Foot Pedal, COMPACT INTUITIV Closed-Toe Foot Pedal
K191933 · Johnson & Johnson Surgical Vision, Inc. · Aug 2019
xPORT Lens Fragmentation System
K191024 · Carl Zeiss Meditec Cataract Technology, Inc. · Aug 2019
CENTURION VISION SYSTEM
K121555 · Alcon Laboratories, Inc. · Dec 2012